Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
5.59
+0.07 (1.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Aardvark Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 122 | 286 | - | - | - |
| Enterprise Value | 12 | 160 | - | - | - |
| Last Close Price | 5.59 | 13.13 | - | - | - |
| PB Ratio | 1.14 | 2.68 | - | - | - |
| P/TBV Ratio | 1.14 | 2.68 | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -1.01 | -1.08 | -0.99 |
| Net Debt / EBITDA Ratio | 1.75 | 1.75 | 3.20 | - | - |
| Net Debt / FCF Ratio | 2.02 | 2.02 | 4.01 | 1.69 | 1.50 |
| Quick Ratio | 10.43 | 10.43 | 14.95 | 7.23 | 27.07 |
| Current Ratio | 10.61 | 10.61 | 15.05 | 7.50 | 27.72 |
| Return on Equity (ROE) | -64.44% | -64.44% | -50.70% | -57.47% | - |
| Return on Assets (ROA) | -40.27% | -40.27% | -32.35% | -33.96% | - |
| Return on Capital Employed (ROCE) | -58.80% | -58.80% | -31.40% | -81.00% | -64.10% |
| Earnings Yield | -47.22% | -20.15% | - | - | - |
| FCF Yield | -44.50% | -18.99% | - | - | - |
| Buyback Yield / Dilution | -391.06% | -391.06% | -0.90% | -1.78% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.